Stereochemistry | ACHIRAL |
Molecular Formula | C16H12Cl2N2O |
Molecular Weight | 319.185 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C3=CC=C(Cl)C=C3
InChI
InChIKey=PUMYFTJOWAJIKF-UHFFFAOYSA-N
InChI=1S/C16H12Cl2N2O/c1-20-14-7-6-12(18)8-13(14)16(19-9-15(20)21)10-2-4-11(17)5-3-10/h2-8H,9H2,1H3
Molecular Formula | C16H12Cl2N2O |
Molecular Weight | 319.185 |
Charge | 0 |
Count |
MOL RATIO
1 MOL RATIO (average) |
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
4'-Chlordiazepam or Ro5-4864 (7-chloro-5- (4-chlorophenyl)-1,3-dihydro-1-methyl-2-H-1,4-benzodiazepine-2)) is a ligand of peripheral-type benzodiazepine receptor (translocator protein or Tspo). It exerts neurosteroidogenic activity. 4'- chlordiazepam is sedative, convulsant and anxiogenic in rodents.
CNS Activity
Originator
Approval Year
PubMed
Patents
Sample Use Guides
mice: 0.00001-10 mg/kg, i.p.
rats: 15-20 mg/kg, i.p.
Route of Administration:
Intraperitoneal